| Advanced Enzyme Technologies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540025 |
NSE Symbol : ADVENZYMES |
P/E(TTM) : 30.18 |
|
ISIN Demat : INE837H01020 |
Div & Yield% : 0.37 |
EPS(TTM) : 12.06 |
|
Book Value(₹) : 63.37 |
Market Cap(₹Cr) : 4,075.37 |
Face Value(₹) : 2.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 116.41 | 95.58 | 115.75 | 125.02 | 87.21 | 100.87 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 116.41 | 95.58 | 115.75 | 125.02 | 87.21 | 100.87 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 5.16 | 1.29 | 3.08 | 53.85 | 4.53 | 1.43 |
| Total Income | 121.57 | 96.88 | 118.83 | 178.88 | 91.74 | 102.30 |
| Total Expenditure | 89.56 | 75.98 | 86.16 | 94.50 | 73.04 | 78.81 |
| PBIDT | 32.02 | 20.90 | 32.67 | 84.38 | 18.70 | 23.49 |
| Interest | 0.06 | 0.05 | 0.05 | 0.05 | 0.08 | 0.06 |
| PBDT | 31.96 | 20.85 | 32.62 | 84.33 | 18.62 | 23.43 |
| Depreciation | 3.12 | 3.04 | 3.00 | 2.93 | 3.11 | 2.89 |
| Tax | 6.77 | 5.58 | 7.28 | 7.44 | 3.55 | 5.33 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.22 | -1.01 | 0.05 | -0.03 | 0.91 | 0.03 |
| Reported Profit After Tax | 22.30 | 13.25 | 22.28 | 73.98 | 11.05 | 15.18 |
| Extra-ordinary Items | 0.00 | -2.65 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 22.30 | 15.90 | 22.28 | 73.98 | 11.05 | 15.18 |
| EPS (Unit Curr.) | 1.99 | 1.18 | 1.99 | 6.61 | 0.99 | 1.36 |
| EPS (Adj) (Unit Curr.) | 1.99 | 1.18 | 1.99 | 6.61 | 0.99 | 1.36 |
| Calculated EPS (Unit Curr.) | 1.99 | 1.18 | 1.99 | 6.61 | 0.99 | 1.36 |
| Calculated EPS (Adj) (Unit Curr.) | 1.99 | 1.18 | 1.99 | 6.61 | 0.99 | 1.36 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.97 | 4.73 | 7.97 | 26.45 | 3.95 | 5.43 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.97 | 4.73 | 7.97 | 26.45 | 3.95 | 5.43 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 22.39 | 22.39 | 22.38 | 22.38 | 22.38 | 22.38 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 27.51 | 21.87 | 28.22 | 67.49 | 21.44 | 23.29 |
| PBDTM(%) | 27.45 | 21.81 | 28.18 | 67.45 | 21.35 | 23.23 |
| PATM(%) | 19.16 | 13.86 | 19.25 | 59.17 | 12.67 | 15.05 |
